ABOUT MZN
Use MZN to boost & strengthen your immunity, especially now during the Covid Pandemic!
MZN is a HEALTH SUPPLEMENT that supports, boosts and strengthens the immune system. It is the perfect supplement during the current Covid19 Pandemic!
It was primarily developed by Dr Kobus du Toit, a well-known scientist and Veterinarian from Pretoria, as a supplement to support Cancer patients undergoing Radio- and Chemotherapy. As matters progressed, it was found to assist in
relieving the symptoms of other ailments
relieving the symptoms of other ailments
reducing Cholesterol
stabilising blood glucose
boosting the immune system of persons with HIV/AIDS and COVID19...
The product is a cream coloured paste that binds the actives in the product. It has an extremely sweet taste that originates from the Stevia plant which is commonly used as an antioxidant.
Ingredients include herbs such as ginger, black pepper, nutmeg, stevia, arnica, rooibos tea, plant sterols and primrose oil.
Dosage: maintenance dose of 1g per 15kg body mass. Mix with a glass of water and drink once a day. If you feel your immune system is weakening, you can drink it twice a day until you feel that your a getting better.
Use after a meal.
STUDIES CONDUCTED
HIV/AIDS:
MZN was provided to the “Village of Hope” in Dodoma, Tanzania, where it was given to approximately 40 orphan children that are HIV positive. MZN was given in combination with anti-retroviral medicine and the children’s viral load and CD4 counts were monitored over time by the Hospital of Rome. In the figure to the left, a decrease in CD4 (white cell count) can be seen with only MZN and a slight increase with ARV and MZN in combination. However, the average white cell count with only MZN is more than in the case with the combination.
The trend that will initially happen is that when the viral load goes down, there will be a decrease in CD4 because of the white cells dying off when fighting the virus.
Cholesterol:
The study was conducted by Prof P.E. Kruger from the Institute for Sport Research at the University of Pretoria. There was a statistically significant decline in the total Cholesterol scores from the onset of the experiment at day 0 until the third month. This decline seemed to be steady from one month to the next with significant decreases from month to month.
There was also a significant decline in the Triglyseride scores. The largest differences occured between the onset of the experiment at day 0 and after 1 month. Secondly, another significant decline occured between 1 and 2 months.
Diabetes:
MZN was given to 14 diabetic patients over a 6 week period and their blood glucose values monitored. The results can be seen in the graph to the left.
MZN has a definite stabilising effect on blood glucose levels. Aside from the benefit to the patient, the secondary benefit is in an increase of approximately 20% to 25% in productivity due to the neutralisation of the feeling of “lethargy” brought about by fluctuating blood glucose levels.